Evidence map›Paper›PMID 26440750›Full record

ArticleBiochemistry2015

Subtle Dynamic Changes Accompany Hck Activation by HIV-1 Nef and are Reversed by an Antiretroviral Kinase Inhibitor.

Thomas E Wales, James M Hochrein, Christopher R Morgan, Lori A Emert-Sedlak, Thomas E Smithgall, John R Engen

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Thomas E WalesDepartment of Chemistry & Chemical Biology, Northeastern University , Boston, Massachusetts 02115, United States.
James M HochreinDepartment of Chemistry & Chemical Biology, Northeastern University , Boston, Massachusetts 02115, United States.
Christopher R MorganDepartment of Chemistry & Chemical Biology, Northeastern University , Boston, Massachusetts 02115, United States.
Lori A Emert-SedlakDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine , Pittsburgh, Pennsylvania 15219, United States.
Thomas E SmithgallDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine , Pittsburgh, Pennsylvania 15219, United States.
John R EngenDepartment of Chemistry & Chemical Biology, Northeastern University , Boston, Massachusetts 02115, United States.
Northeastern University · USUniversity of Pittsburgh · US

Funding

Small Molecule Inhibitors of HIV Nef SignalingR01AI057083 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SMITHGALL, THOMAS E. · 2003 to 2019
$5.1M
Structural Biology of HIV-1 Nef with Host Effectors and Small Molecule InhibitorsR01AI102724 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ALVARADO, JOHN JEFF, SMITHGALL, THOMAS E. · 2013 to 2017
$1.9M
Protein conformational change upon membrane associationR01GM086507 · NIGMS · NORTHEASTERN UNIVERSITY · PI ENGEN, JOHN R · 2009 to 2012
$1.6M
Extending the applications of hydrogen exchange mass spectrometryR01GM101135 · NIGMS · NORTHEASTERN UNIVERSITY · PI ENGEN, JOHN R · 2012 to 2015
$1.2M
Structural Biology of HIV-1 Nef with Host Effectors and Small Molecule InhibitorsR56AI102724 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SMITHGALL, THOMAS E. · 2019 to 2019
$468k
NIAID NIH HHS AI057083NIAID NIH HHS AI102724NIAID NIH HHS R01 AI057083NIAID NIH HHS R01 AI102724NIAID NIH HHS R56 AI102724NIGMS NIH HHS GM086507NIGMS NIH HHS GM101135NIGMS NIH HHS R01 GM086507NIGMS NIH HHS R01 GM101135
6 · The paper itself

Abstract

The HIV-1 virulence factor Nef interacts with the macrophage Src-family kinase Hck, resulting in constitutive kinase activation that contributes to viral replication and immune escape. Previous chemical library screens identified the diphenylfuranopyrimdine kinase inhibitor DFP-4AB, which selectively inhibits Nef-dependent Hck activity in biochemical assays and potently blocks HIV replication in vitro. In the present study, hydrogen exchange mass spectrometry (HX MS) was used to study conformational changes in downregulated Hck that result from Nef binding, as well as the impact of DFP-4AB on these changes. Remarkably, interaction with Nef induced only subtle changes in deuterium uptake by Hck, with the most significant changes in the N-lobe of the kinase domain adjacent to the docking site for Nef on the SH3 domain. No changes in hydrogen exchange were observed in the Hck SH2 domain or C-terminal tail, indicating that this regulatory interaction is unaffected by Nef binding. When HX MS was performed in the presence of DFP-4AB, the effect of Nef on Hck N-lobe dynamics was completely reversed. These results show that constitutive activation of Hck by HIV-1 Nef requires only modest changes to the conformational dynamics of the overall kinase structure. DFP-4AB reverses these effects, consistent with its activity against this Nef-induced signaling event in HIV-infected cells.

Indexed as

Enzyme ActivationHIV-1HIV InfectionsHumansMolecular Docking SimulationMolecular Dynamics Simulationnef Gene Products, Human Immunodeficiency VirusProtein ConformationProtein Interaction MapsProtein Kinase InhibitorsProto-Oncogene Proteins c-hcksrc Homology DomainsVirus ReplicationHCK protein, humannef Gene Products, Human Immunodeficiency VirusProtein Kinase InhibitorsProto-Oncogene Proteins c-hck

Identifiers

PMID26440750
PMCPMC4615603
OpenAlexW2301801204

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.